Qing Song Health Co.,Ltd. (TPE:6931)
Taiwan · Delayed Price · Currency is TWD 41.90
+1.30 (3.20%)
At close: May 18, 2026
Qing Song Health Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 127.49 | 91.7 | 40.55 | 59.4 | 23.33 | -1.97 |
Depreciation & Amortization | 144.41 | 141.95 | 129.72 | 109.16 | 95.12 | 71.52 |
Other Amortization | 0.27 | 0.27 | 0.35 | 0.46 | 0.64 | 0.62 |
Loss (Gain) From Sale of Assets | 1 | 1.01 | 0.61 | 0.97 | 0.29 | -0.01 |
Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.04 |
Loss (Gain) on Equity Investments | - | - | - | - | - | 0.16 |
Provision & Write-off of Bad Debts | 0.19 | 1.18 | 0.04 | 0.31 | - | -0.02 |
Other Operating Activities | 3.38 | -3.27 | -21.11 | 3.02 | 0.19 | -5.05 |
Change in Accounts Receivable | -4.96 | -14.6 | -4.53 | -15.48 | 35.77 | 19.52 |
Change in Inventory | -0.35 | -0.28 | -0.19 | 0.02 | 3.57 | -1.17 |
Change in Accounts Payable | 9.91 | 6.73 | -4.39 | 6.4 | -1.19 | 4.62 |
Change in Unearned Revenue | 6 | 6 | 6.36 | -12.1 | -16.84 | 35.79 |
Change in Other Net Operating Assets | 19.75 | -28.18 | 65.37 | -130.41 | 2.86 | 0.3 |
Operating Cash Flow | -98.31 | -71.63 | 209.97 | 21.6 | 130.19 | 124.28 |
Operating Cash Flow Growth | - | - | 872.20% | -83.41% | 4.76% | 1681.72% |
Capital Expenditures | -103.77 | -80.49 | -86.83 | -43.86 | -95.34 | -110.45 |
Sale of Property, Plant & Equipment | 0.34 | 0.38 | - | - | 0.58 | 0.28 |
Cash Acquisitions | 0.25 | - | -9.72 | - | - | - |
Sale (Purchase) of Intangibles | - | - | -0.48 | - | -0.38 | -0.32 |
Sale (Purchase) of Real Estate | - | - | -18.31 | - | - | - |
Investment in Securities | 60.11 | 0.7 | - | - | 4.5 | 0.28 |
Other Investing Activities | -0.49 | -2.73 | -18.76 | -9.1 | -4.27 | 3.78 |
Investing Cash Flow | -43.56 | -82.13 | -134.09 | -52.96 | -94.9 | -106.44 |
Short-Term Debt Issued | - | - | 60 | - | - | - |
Long-Term Debt Issued | - | - | 7.73 | - | 20 | - |
Total Debt Issued | - | - | 67.73 | - | 20 | - |
Short-Term Debt Repaid | - | -60 | - | - | - | - |
Long-Term Debt Repaid | - | -101.02 | -76.78 | -65.44 | -58.98 | -44.62 |
Total Debt Repaid | -124.1 | -161.02 | -76.78 | -65.44 | -58.98 | -44.62 |
Net Debt Issued (Repaid) | -124.1 | -161.02 | -9.04 | -65.44 | -38.98 | -44.62 |
Issuance of Common Stock | - | 452.9 | - | - | - | 70 |
Common Dividends Paid | -47.63 | -39.69 | -4.97 | -1.06 | - | - |
Other Financing Activities | -0.58 | 13.94 | -9.79 | 5.39 | 33.74 | 22.27 |
Financing Cash Flow | -172.3 | 266.13 | -23.8 | -61.11 | -5.23 | 47.66 |
Net Cash Flow | -314.17 | 112.37 | 52.08 | -92.47 | 30.05 | 65.49 |
Free Cash Flow | -202.08 | -152.12 | 123.14 | -22.26 | 34.85 | 13.83 |
Free Cash Flow Growth | - | - | - | - | 152.01% | - |
Free Cash Flow Margin | -17.30% | -13.56% | 12.53% | -2.56% | 5.47% | 3.87% |
Free Cash Flow Per Share | -3.06 | -2.31 | 2.05 | -0.37 | 0.58 | 0.23 |
Cash Interest Paid | 25.39 | 25.39 | 23.06 | 17.47 | 14.05 | 11.32 |
Cash Income Tax Paid | 16.25 | 16.25 | 24.92 | 16.12 | 3.52 | 5.92 |
Levered Free Cash Flow | 17.09 | 97.32 | 58.82 | 82.96 | 55.88 | 22.74 |
Unlevered Free Cash Flow | 33.36 | 113.11 | 73.2 | 93.98 | 64.63 | 29.8 |
Change in Working Capital | -375.04 | -304.47 | 59.8 | -151.72 | 10.61 | 59.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.